Rivaroxaban (10mg) Given Once Daily in Patients Undergoing Total Hip Replacement Compared to Enoxaparin

Clinical trial NCT00329628 · COMPLETED

Trial details

NCT number: NCT00329628
Sponsor: Bayer
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Venous Thromboembolism

Start date: 2006-02-01
Primary completion: 2007-03-01
Enrollment: 4541

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.